Cancer is set to become the biggest cause of death and disability in Europe. Healthcare systems are trying to tackle increasing cancer incidence by designing care pathways based on what they believe can deliver the greatest value.
However, there are currently wide variations among different perceptions of what constitutes valuable innovation in cancer treatment. These disparities are often translated into different decisions and policies. There is therefore a need to clearly communicate and try to bridge these different views between cancer care stakeholders and decision-makers in Europe in order to foster effective policymaking.
Attending the European Cancer Congress (ECCO) 2017?
If so, join leading experts from the clinical, patient, industry and policy spheres on Saturday 28th January for a policy debate on how to navigate different perspectives on value in oncology innovation.
28 January 2017 | 15:00-16:30 | Industry Spotlight Area
European Cancer Congress 2017, Amsterdam
To register, please fill in the fields below. We look forward to seeing you there!
